{
    "nctId": "NCT00638391",
    "briefTitle": "Ax-003/Arimidex (Anastrozole) in the Adjuvant Therapy of Early Breast Cancer",
    "officialTitle": "Postmenopausal Women With Early Hormone-Receptor Positive Breast Cancer/no Metastasis",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 1600,
    "primaryOutcomeMeasure": "evaluation of Anastrozole therapy as adjuvant treatment in post.menopausal women with not advanced breast cancer \u00fander naturalistic conditions",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Postmenopausal women with early hormone receptor positive breast cancer/no metastasis\n\nExclusion Criteria:\n\n* None",
    "sex": "FEMALE",
    "minimumAge": "N/A",
    "stdAges": "CHILD, ADULT, OLDER_ADULT"
}